Literature DB >> 23563397

Building a wall against biosimilars.

.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23563397     DOI： 10.1038/nbt.2550

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  6 in total

1.  First US biosimilar launch.

Authors: 
Journal:  Nat Biotechnol       Date:  2015-10       Impact factor: 54.908

2.  First US biosimilar edges towards market.

Authors:  Melanie Senior
Journal:  Nat Biotechnol       Date:  2015-03       Impact factor: 54.908

3.  What's fueling the biotech engine-2012 to 2013.

Authors:  Rob Saurabh Aggarwal
Journal:  Nat Biotechnol       Date:  2014-01       Impact factor: 54.908

4.  Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice Messaging.

Authors:  Liese Barbier; Allary Mbuaki; Steven Simoens; Paul Declerck; Arnold G Vulto; Isabelle Huys
Journal:  Front Med (Lausanne)       Date:  2022-03-09

5.  Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines.

Authors:  Arnold G Vulto; Isabelle Huys; Yannick Vandenplas; Steven Simoens; Florian Turk
Journal:  Appl Health Econ Health Policy       Date:  2022-08-16       Impact factor: 3.686

6.  The Importance of Countering Biosimilar Disparagement and Misinformation.

Authors:  Hillel P Cohen; Dorothy McCabe
Journal:  BioDrugs       Date:  2020-08       Impact factor: 5.807
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.